Evolving revascularization approaches for myocardial ischemia.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  American Journal of Cardiology

• Publication date

  2003-11-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0002-9149(03)00963-9PMID 14615021
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transmyocardial Revascularization Transmyocardial Revascularization With CO 2 Laser in Patients With Refractory Angina Pectoris Clinical Results from The Norwegian Randomized Trial

  2016cited by this paper
• Clinical and Angiographic Characteristics of 236 Coronary Segments Treated by Coronary Atherectomy or Stenting Patients

  2005cited by this paper
• TAXUS I: Six- and Twelve-Month Results From a Randomized, Double-Blind Trial on a Slow-Release Paclitaxel-Eluting Stent for De Novo Coronary Lesions

  2003cited by this paper
• ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina).

  2003cited by this paper
• Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chronic Myocardial Ischemia: Phase II Results of the Kuopio Angiogenesis Trial (KAT)

  2003cited by this paper
• VEGF-D Is the Strongest Angiogenic and Lymphangiogenic Effector Among VEGFs Delivered Into Skeletal Muscle via Adenoviruses

  2003cited by this paper
• Initial experience with paclitaxel-coated stents.

  2002cited by this paper
• Ernest Henry Starling, His Predecessors, and the “Law of the Heart”

  2002cited by this paper
• The embryonic angiogenic factor Del1 accelerates tumor growth by enhancing vascular formation.

  2002cited by this paper
• Clinical and Physiological Effects of an Acute &agr;-1 Adrenergic Agonist and a &bgr;-1 Adrenergic Antagonist in Chronic Orthostatic Intolerance

  2002cited by this paper
• 7-Hexanoyltaxol–Eluting Stent for Prevention of Neointimal Growth: An Intravascular Ultrasound Analysis From the Study to COmpare REstenosis rate between QueST and QuaDS-QP2 (SCORE)

  2002cited by this paper
• Angiopoietin-1 reduces cerebral blood vessel leakage and ischemic lesion volume after focal cerebral embolic ischemia in mice.

  2002cited by this paper
• Endoscopic radial artery harvesting: results of first 300 patients.

  2002cited by this paper
• Angiogenic Gene Therapy (AGENT) Trial in Patients With Stable Angina Pectoris

  2002cited by this paper
• Angiographic Findings of the Multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): Sirolimus-Eluting Stents Inhibit Restenosis Irrespective of the Vessel Size

  2002cited by this paper
• Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration.

  2002cited by this paper
• A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.

  2002cited by this paper
• The St Jude Medical symmetry aortic connector system for proximal vein graft anastomoses in coronary artery bypass grafting.

  2002cited by this paper
• Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein.

  2002cited by this paper
• Platelet-derived growth factor-AA-mediated functional angiogenesis in the rat epigastric island flap after genetic modification of fibroblasts is ischemia dependent.

  2002cited by this paper
• Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study.

  2002cited by this paper
• Coronary hybrid revascularization from January 1997 to January 2001: a clinical follow-up.

  2002cited by this paper
• VEGF gene delivery for treatment of ischemic cardiovascular disease.

  2002cited by this paper
• The role of fibroblast growth factors in vascular development.

  2002cited by this paper
• Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2: Double-Blind, Randomized, Controlled Clinical Trial

  2002cited by this paper
• Primary stenting versus MIDCAB: preliminary report-comparision of two methods of revascularization in single left anterior descending coronary artery stenosis.

  2002cited by this paper
• The effect off-pump coronary artery bypass surgery on in-hospital mortality and morbidity.

  2002cited by this paper
• Therapeutic Angiogenesis for Coronary Artery Disease

  2002cited by this paper
• Phase 1/2 Placebo-Controlled, Double-Blind, Dose-Escalating Trial of Myocardial Vascular Endothelial Growth Factor 2 Gene Transfer by Catheter Delivery in Patients With Chronic Myocardial Ischemia

  2002cited by this paper
• Intramyocardial injection of naked DNA encoding HIF-1alpha/VP16 hybrid to enhance angiogenesis in an acute myocardial infarction model in the rat.

  2002cited by this paper
• Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary Arteries: A Quantitative Coronary Angiography and Three-Dimensional Intravascular Ultrasound Study

  2001cited by this paper
• Promotion of Collateral Growth by Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Coronary Artery Disease: A Randomized, Double-Blind, Placebo-Controlled Study

  2001cited by this paper
• Sustained Suppression of Neointimal Proliferation by Sirolimus-Eluting Stents: One-Year Angiographic and Intravascular Ultrasound Follow-Up

  2001cited by this paper
• Angiogenesis, Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor-BB Expression, Iron Deposition, and Oxidation-Specific Epitopes in Stented Human Coronary Arteries

  2001cited by this paper
• Del1 mediates VSMC adhesion, migration, and proliferation through interaction with integrin alpha(v)beta(3).

  2001cited by this paper
• Does the completeness of revascularization affect early survival after coronary artery bypass grafting in elderly patients?

  2001cited by this paper
• Minimally invasive CABG

  2001cited by this paper
• Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary.

  2000cited by this paper
• Catheter-Mediated Vascular Endothelial Growth Factor Gene Transfer to Human Coronary Arteries after Angioplasty

  2000cited by this paper
• Induction of angiogenesis after TMR: a comparison of holmium: YAG, CO2, and excimer lasers.

  2000cited by this paper
• Catheter-based transendocardial gene delivery for therapeutic myocardial angiogenesis

  2000cited by this paper
• Novel molecular therapeutic approach to cardiovascular disease based on hepatocyte growth factor.

  2000cited by this paper
• Cardiovascular gene therapy.

  2000cited by this paper
• Therapeutic angiogenesis induced by hepatocyte growth factor: potential gene therapy for ischemic diseases.

  2000cited by this paper
• Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris. Clinical results from the Norwegian randomized trial.

  2000cited by this paper
• Therapeutic Angiogenesis With Recombinant Fibroblast Growth Factor-2 Improves Stress and Rest Myocardial Perfusion Abnormalities in Patients With Severe Symptomatic Chronic Coronary Artery Disease

  2000cited by this paper
• The revival of surgical treatment for isolated proximal high grade LAD lesions by minimally invasive coronary artery bypass grafting.

  2000cited by this paper
• Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy. Results in normal and ischemic porcine models.

  2000cited by this paper
• Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study.

  2000cited by this paper
• Transmyocardial laser revascularization combined with coronary artery bypass grafting: a multicenter, blinded, prospective, randomized, controlled trial.

  2000cited by this paper
• Angiogenesis Is Induced in a Rabbit Model of Hindlimb Ischemia by Naked DNA Encoding an HIF-1&agr;/VP16 Hybrid Transcription Factor

  2000cited by this paper
• Routine minimal invasive vein harvesting reduces postoperative morbidity in cardiac bypass procedures. Clinical report of 1400 patients.

  1999cited by this paper
• Minimally invasive saphenous vein harvesting: is there an improvement of the results with the endoscopic approach?

  1999cited by this paper
• Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial.

  1999cited by this paper
• Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. ATLANTIC Investigators. Angina Treatments-Lasers and Normal Therapies in Comparison.

  1999cited by this paper
• Cardiac sympathetic denervation after transmyocardial laser revascularization.

  1999cited by this paper
• Pathology of in-stent restenosis.

  1999cited by this paper
• Endoscopic coronary artery bypass grafting with the aid of robotic assisted instruments.

  1999cited by this paper
• Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease.

  1999cited by this paper
• Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial.

  1999cited by this paper
• Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina.

  1999cited by this paper
• Minimally invasive saphenous vein harvesting.

  1998cited by this paper
• Endoscopic versus traditional saphenous vein harvesting: a prospective, randomized trial.

  1998cited by this paper
• Adenovirus-Mediated Gene Transfer to Lower Limb Artery of Patients with Chronic Critical Leg Ischemia

  1998cited by this paper
• Minimally-invasive, direct coronary artery bypass grafting.

  1998cited by this paper
• Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia.

  1998cited by this paper
• Angiogenesis is enhanced in ischemic canine myocardium by transmyocardial laser revascularization.

  1998cited by this paper
• Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease.

  1998cited by this paper
• Minimally invasive direct coronary artery bypass grafting: two-year clinical experience.

  1997cited by this paper
• Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology.

  1997cited by this paper
• Endoscopic saphenous vein harvesting.

  1997cited by this paper
• Transmyocardial laser treatment denervates canine myocardium.

  1997cited by this paper
• Assessment of transmyocardial perfusion in alligator hearts.

  1997cited by this paper
• Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb.

  1996cited by this paper
• Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance.

  1995cited by this paper
• Frequency of repeat coronary bypass or coronary angioplasty after coronary artery bypass surgery using saphenous venous grafts.

  1994cited by this paper
• A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators.

  1994cited by this paper
• Intracoronary stents: a review of the experience with five different devices in clinical use.

  1994cited by this paper
• A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group.

  1994cited by this paper
• A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators.

  1992cited by this paper
• The Importance of Acute Luminal Diameter in Determining Restenosis After Coronary Atherectomy or Stenting

  1992cited by this paper
• Angiographic follow-up after placement of a self-expanding coronary-artery stent.

  1991cited by this paper
• Intracoronary stents: will they fulfill their promise as an adjunct to angioplasty?

  1989cited by this paper

• Natural Herbal Medicine as a Treatment Strategy for Myocardial Infarction through the Regulation of Angiogenesis

  2022cites this paper
• Avances en la cardiopatía isquémica aguda y crónica

  2017cites this paper
• Magnetic Resonance Imaging in Guidance and Assessement of Cardiovasular Interventions

  2017cites this paper
• activation in myocardium early after infarction Targeted imaging of hypoxia-induced integrin

  2015cites this paper
• Blood flow to the heart from noncoronary arteries: an intriguing but challenging research field.

  2012cites this paper
• MR fluoroscopy in vascular and cardiac interventions

  2012cites this paper
• Osmotic release of bioactive VEGF from biodegradable elastomer monoliths is the same in vivo as in vitro.

  2012cites this paper
• Delivery approaches for angiogenic growth factors in the treatment of ischemic conditions

  2011cites this paper
• L’augmentation de la circulation collatérale non coronarienne : l’hypothèse d’une méthode alternative de revascularisation myocardique

  2011cites this paper
• MR fluoroscopy in vascular and cardiac interventions (review)

  2011cites this paper
• Enhancement of noncoronary collateral circulation: the hypothesis of an alternative treatment for ischemic heart disease.

  2010cites this paper
• Novel Minicircle Vector for Gene Therapy in Murine Myocardial Infarction

  2009cites this paper
• Cardioprotective effects of tanshinone IIA on myocardial ischemia injury in rats.

  2009cites this paper
• Targeted imaging of hypoxia-induced integrin activation in myocardium early after infarction.

  2008cites this paper
• Histopathological validation of electromechanical mapping in assessing myocardial viability in a porcine model of chronic ischemia.

  2008cites this paper
• Demographics and changes in medical/interventional treatment of coronary artery disease patients over a 3.5-year period in Japan: the Japanese Coronary Artery Disease Study: trend examination.

  2008cites this paper
• Drug-Eluting Stents: An Update

  2007cites this paper
• Radionuclide reporter gene imaging for cardiac gene therapy

  2007cites this paper
• Efeito do VEGF na angiogênese pulpar e na apoptose

  2006cites this paper
• Chapter 141 – Intraocular Neovascularization

  2006cites this paper
• Gene Therapy for Angiogenesis

  2006cites this paper
• Sleeping beauty transposon-mediated gene therapy for prolonged expression.

  2005cites this paper
• Stimulation of Paracrine Pathways With Growth Factors Enhances Embryonic Stem Cell Engraftment and Host-Specific Differentiation in the Heart After Ischemic Myocardial Injury

  2005cites this paper
• Injury Engraftment and Host-Specific Differentiation in the Heart After Ischemic Myocardial Stimulation of Paracrine Pathways With Growth Factors Enhances Embryonic Stem Cell

  2005cites this paper
• Positron Emission Tomography Reporter Gene Imaging in the Myocardium: For Monitoring of Angiogenic Gene Therapy in Ischemic Heart Disease

  2005cites this paper
• Nitric oxide and the angiogenic response: can we improve the results of therapeutic angiogenesis?

  2005cites this paper
• Therapeutic angiogenesis for coronary artery disease: clinical trials of proteins, plasmids, adenovirus and stem cells.

  2005cites this paper
• Diferenças na resposta inflamatória e implante eletivo de stent coronário entre pacientes com e sem diabetes mellitus

  2005cites this paper
• Fibroblast Growth Factor Receptor-1 Function in Vasculo- and Angiogenesis

  2005cites this paper
• Laser Literature Watch

  2004cites this paper
• Current world literature Arrhythmias

  2004cites this paper
• Implantation and characterization of tissue engineered microvascular grafts

  2004cites this paper
• Recent advances in minimal-access cardiac surgery using robotic-enhanced surgical systems

  2004cites this paper
• Angiogenesis and lymphangiogenesis: highlights of the past year

  2004cites this paper
• 1.狭心症診療:基本と最近の進歩

  2004cites this paper
• Minimal access coronary revascularisation without cardiopulmonary bypass—the impact of robotic technology in the current clinical practice

  2004cites this paper
• Current options in the management of coronary artery disease.

  2003cites this paper
• Novel Minicircle Vector for Gene Therapy in Murine Myocardial Infarction Novel Minicircle Vector for Gene Therapy in Murine Myocardial Infarction

  year unknowncites this paper